SkinHealth Systems Inc. (SKIN) stock
SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$13.88−1.18 (-7.81%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
SkinHealth Systems cash
Cash and short-term investments held at the end of each period.
SkinHealth Systems's cash was $206.07M at Jun 30, 2026. For fiscal 2025 it was $232.67M, down 37.1% from the year before. The highest annual figure on record is $901.89M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $232.67M | -37.1% |
| FY2024 | Dec 31, 2024 | $370.06M | -29.2% |
| FY2023 | Dec 31, 2023 | $523.03M | -8.0% |
| FY2022 | Dec 31, 2022 | $568.20M | -37.0% |
| FY2021 | Dec 31, 2021 | $901.89M | +9407.5% |
| FY2020 | Dec 31, 2020 | $9.49M | +29.8% |
| FY2019 | Dec 31, 2019 | $7.31M | +104.4% |
| FY2018 | Dec 31, 2018 | $3.58M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $206.07M | -2.8% |
| Q1 FY2026 | Mar 31, 2026 | $204.36M | -45.2% |
| Q4 FY2025 | Dec 31, 2025 | $232.67M | -37.1% |
| Q3 FY2025 | Sep 30, 2025 | $219.40M | -38.9% |
| Q2 FY2025 | Jun 30, 2025 | $212.00M | -39.3% |
| Q1 FY2025 | Mar 31, 2025 | $373.03M | -16.1% |
| Q4 FY2024 | Dec 31, 2024 | $370.06M | -29.2% |
| Q3 FY2024 | Sep 30, 2024 | $358.89M | -35.8% |
| Q2 FY2024 | Jun 30, 2024 | $349.54M | -36.4% |
| Q1 FY2024 | Mar 31, 2024 | $444.63M | -16.5% |
| Q4 FY2023 | Dec 31, 2023 | $523.03M | -8.0% |
| Q3 FY2023 | Sep 30, 2023 | $559.44M | -18.2% |
| Q2 FY2023 | Jun 30, 2023 | $549.73M | -33.0% |
| Q1 FY2023 | Mar 31, 2023 | $532.28M | -38.1% |
| Q4 FY2022 | Dec 31, 2022 | $568.20M | -37.0% |
| Q3 FY2022 | Sep 30, 2022 | $684.21M | -4.8% |
| Q2 FY2022 | Jun 30, 2022 | $820.97M | +709.1% |
| Q1 FY2022 | Mar 31, 2022 | $859.24M | +5987.4% |
| Q4 FY2021 | Dec 31, 2021 | $901.89M | +9407.5% |
| Q3 FY2021 | Sep 30, 2021 | $718.62M | +5965.3% |
| Q2 FY2021 | Jun 30, 2021 | $101.47M | +593.9% |
| Q1 FY2021 | Mar 31, 2021 | $14.12M | +93.2% |
| Q4 FY2020 | Dec 31, 2020 | $9.49M | +165.3% |
| Q3 FY2020 | Sep 30, 2020 | $11.85M | – |
| Q2 FY2020 | Jun 30, 2020 | $14.62M | – |
| Q4 FY2019 | Dec 31, 2019 | $7.31M | – |
| Q4 FY2018 | Dec 31, 2018 | $3.58M | – |
See a number that looks wrong?